| Panobinostat studied in …STUDIED_INderived119 of 119show fewer |
|---|
| → studied in | NCT02386800Phase 4 · active not recruiting CINC424A2X01B Rollover Protocol · 119 trials list this drug (2 active) | — | — | Acute Myeloid Leukemia,Polycythemia Vera,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04804709Phase 1 · terminated Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG) · 119 trials list this drug (2 active) | — | — | Diffuse Intrinsic Pontine Glioma,Diffuse Midline Glioma, H3 K27M-Mutant | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01324635Phase 1 · terminated Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors · 119 trials list this drug (2 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02506959Phase 2 · completed Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma,Plasma Cell Leukemia,Plasmacytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897880Phase 2 · terminated A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT · 119 trials list this drug (2 active) | — | — | Rhabdoid Tumor,Atypical Teratoid/Rhabdoid Tumor,Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02654990Phase 2 · completed Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04956302Phase 1 · terminated Panobinostat in Combination With Daratumumab, Bortezomib and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02717455Phase 1 · completed Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma · 119 trials list this drug (2 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 119 trials list this drug (2 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04341311Phase 1 · terminated Phase I Study of Marizomib + Panobinostat for Children With DIPG · 119 trials list this drug (2 active) | — | — | Childhood Malignant Neoplasm,Diffuse Glioma,Childhood Brain Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01301807Phase 1 · completed Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma,Non-Secretory Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04150289completed A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01238692Phase 2 · completed A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL) · 119 trials list this drug (2 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05725200Phase 2 · recruiting Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer · 119 trials list this drug (2 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04326764Phase 3 · terminated Panobinostat Maintenance After HSCT fo High-risk AML and MDS · 119 trials list this drug (2 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02032810Phase 1 · completed Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma · 119 trials list this drug (2 active) | — | — | Malignant Skin Neoplasm,Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02890069Phase 1 · completed A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat · 119 trials list this drug (2 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02722941Phase 2 · completed Panobinostat (LBH589): Multiple Myeloma - Autologous Hematopoietic Cell Transplantation (HCT) · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01582009Phase 1/Phase 2 · terminated Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate · 119 trials list this drug (2 active) | — | — | Clear Cell Renal Cell Carcinoma,Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01261247Phase 2 · completed Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma · 119 trials list this drug (2 active) | — | — | Anaplastic Large Cell Lymphoma,Adult Lymphoblastic Lymphoma,Adult T-Cell Leukemia/Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03256045Phase 2 · terminated Panobinostat, Carfilzomib, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01658241Phase 2 · completed Panobinostat Biological Correlates Study · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01496118Phase 1/Phase 2 · completed Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00550277Phase 2 · completed LBH589 Treatment for Refractory Clear Cell Renal Carcinoma · 119 trials list this drug (2 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01965353Phase 1 · completed A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00425555Phase 2 · completed Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma · 119 trials list this drug (2 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00490776Phase 2 · terminated Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL) · 119 trials list this drug (2 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00742027Phase 2 · completed Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma · 119 trials list this drug (2 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00449761Phase 2 · terminated Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase · 119 trials list this drug (2 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00451035Phase 2 · terminated Efficacy and Safety of LBH589 in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Chronic Phase · 119 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445068Phase 2 · terminated Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00667862Phase 2 · completed Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancer · 119 trials list this drug (2 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00936611Phase 2 · completed LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia · 119 trials list this drug (2 active) | — | — | Waldenstrom Macroglobulinemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01169636Phase 1/Phase 2 · completed Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma · 119 trials list this drug (2 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00621244Phase 1/Phase 2 · completed A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies · 119 trials list this drug (2 active) | — | — | Leukemia,Lymphoma,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00493766Phase 1 · terminated Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone · 119 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503451Phase 1 · completed A Study to Investigate the Effects of Ketoconazole on LBH589 in Patients With Advanced Solid Tumors · 119 trials list this drug (2 active) | — | — | Neoplasm,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00532389Phase 1 · completed Safety Study of LBH589 When Given in Combination With Bortezomib in Adult Patients With Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00532675Phase 1 · completed Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma. · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00535951Phase 1 · completed Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma · 119 trials list this drug (2 active) | — | — | Malignant Mesothelioma,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00570284Phase 1 · completed A Study to Investigate the Effect of Food on Oral LBH589 Absorption in Patients With Advanced Solid Tumors · 119 trials list this drug (2 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00663832Phase 1 · completed A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer · 119 trials list this drug (2 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00739414Phase 1 · completed Dose-escalating Study of LBH589 in Adult Patients With Advanced Solid Tumors · 119 trials list this drug (2 active) | — | — | Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00788931Phase 1 · completed A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer · 119 trials list this drug (2 active) | — | — | Breast Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00997399Phase 1 · completed Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function · 119 trials list this drug (2 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01007968Phase 1 · completed Pharmacokinetics and Safety of Panobinostat in Patients With Advanced Solid Tumors and Various Degrees of Hepatic Function · 119 trials list this drug (2 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01242774Phase 1 · completed Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML) · 119 trials list this drug (2 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01613976Phase 1 · completed A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients · 119 trials list this drug (2 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946647Phase 1/Phase 2 · completed A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML). · 119 trials list this drug (2 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myelomonocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568943no longer available An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01023308Phase 3 · completed Panobinostat or Placebo With Bortezomib and Dexamethasone in Patients With Relapsed Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00918333Phase 1/Phase 2 · completed Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma · 119 trials list this drug (2 active) | — | — | Anaplastic Large Cell Lymphoma,Multiple Myeloma,Adult Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02057640Phase 1/Phase 2 · completed MLN9708 (Ixazomib) in Combination With Panobinostat and Dexamethasone in Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00985946Phase 2 · terminated Study of Panobinostat in Patients With Neuroendocrine Tumors · 119 trials list this drug (2 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01802879Phase 2 · completed Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator · 119 trials list this drug (2 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01013597Phase 2 · completed Trial of LBH589 in Metastatic Thyroid Cancer · 119 trials list this drug (2 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01523834Phase 2 · completed Oral Panobinostat Adult Patients DLBCL Relapsed/Refractory Stem Cell Transfusion (ASCT) or Not Eligible for ASCT · 119 trials list this drug (2 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02290431Phase 2 · completed Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03982134Phase 1 · withdrawn PDR001 + Panobinostat for Melanoma and NSCLC · 119 trials list this drug (2 active) | — | — | Melanoma,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03632317Phase 2 · withdrawn A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas · 119 trials list this drug (2 active) | — | — | Glioma,Diffuse Intrinsic Pontine Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01463046Phase 1 · completed Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome · 119 trials list this drug (2 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02518750Phase 2 · terminated Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma · 119 trials list this drug (2 active) | — | — | Leukemia,Acute Lymphoblastic Leukemia,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01440582Phase 1 · completed Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01549431Phase 1 · completed Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00840346Phase 1/Phase 2 · completed Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML) · 119 trials list this drug (2 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02676323Phase 1 · terminated Panobinostat With Fludarabine and Cytarabine for Treatment of Children With Acute Myeloid Leukemia or Myelodysplastic Syndrome · 119 trials list this drug (2 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00939159Phase 2 · terminated Study of LBH589 for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) · 119 trials list this drug (2 active) | — | — | Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02720510Phase 2 · terminated A Trial Evaluating Efficacy & Safety of RVD +/- Panobinostat in Transplant Eligible, Newly Diagnosed Multiple Myeloma (NDMM) · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01651039Phase 2 · completed Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM) · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01451268Phase 1/Phase 2 · unknown Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) · 119 trials list this drug (2 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00878436Phase 1/Phase 2 · completed Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration · 119 trials list this drug (2 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01056601Phase 2 · terminated Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy · 119 trials list this drug (2 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01083602Phase 2 · completed Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01460940Phase 2 · completed A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma · 119 trials list this drug (2 active) | — | — | Adult Hodgkin Lymphoma,Adult Nodular Lymphocyte Predominant B-Cell Lymphoma,Adult Mixed Cellularity Classic Hodgkin Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01105312Phase 1/Phase 2 · completed Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer · 119 trials list this drug (2 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00670553Phase 1 · completed A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer · 119 trials list this drug (2 active) | — | — | Malignant Esophageal Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02802163Phase 1/Phase 2 · withdrawn Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02961816Phase 2 · withdrawn Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma · 119 trials list this drug (2 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01065467Phase 1 · completed Panobinostat (LBH589) in Patients With Metastatic Melanoma · 119 trials list this drug (2 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00878904Phase 1 · completed Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors · 119 trials list this drug (2 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00859222Phase 1/Phase 2 · completed LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma · 119 trials list this drug (2 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00993642early Phase 1 · withdrawn ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer · 119 trials list this drug (2 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00880269Phase 2 · completed Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML) · 119 trials list this drug (2 active) | — | — | Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01032148Phase 1 · terminated Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma · 119 trials list this drug (2 active) | — | — | Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00978432Phase 2 · terminated Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) · 119 trials list this drug (2 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02756663Phase 2 · withdrawn Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00691938Phase 1/Phase 2 · completed LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML) · 119 trials list this drug (2 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00777049Phase 2 · completed Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer · 119 trials list this drug (2 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01034163Phase 3 · completed A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL) · 119 trials list this drug (2 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00567879Phase 1/Phase 2 · terminated A Trial of Panobinostat and Trastuzumab for Adult Female Patients With HER2 Positive Metastatic Breast Cancer (MBC) Whose Disease Has Progressed on or After Trastuzumab · 119 trials list this drug (2 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02204553no longer available Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00777335Phase 2 · terminated Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer · 119 trials list this drug (2 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01321346Phase 1 · completed A Study Of Panobinostat In Children With Refractory Hematologic Malignancies · 119 trials list this drug (2 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Non-Hodgkin Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00907179Phase 1 · terminated Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer · 119 trials list this drug (2 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02145715Phase 1/Phase 2 · unknown Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00632489Phase 1 · completed LBH589 in Combination With Capecitabine Plus/Minus (±) Lapatinib in Breast Cancer Patients · 119 trials list this drug (2 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01238965Phase 1 · terminated Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy · 119 trials list this drug (2 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01298934Phase 1/Phase 2 · unknown LBH589 (Panobinostat) for the Treatment of Myelofibrosis · 119 trials list this drug (2 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00967044Phase 1/Phase 2 · completed Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma · 119 trials list this drug (2 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00891033Phase 1 · terminated Panobinostat/Velcade in Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00738751Phase 1 · completed Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers · 119 trials list this drug (2 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01160731Phase 1 · withdrawn Panobinostat, Etoposide, and Cisplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer · 119 trials list this drug (2 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01504776Phase 1 · completed Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL) · 119 trials list this drug (2 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00723203Phase 2 · terminated Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia · 119 trials list this drug (2 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00686218Phase 1 · completed Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia · 119 trials list this drug (2 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00743288Phase 1/Phase 2 · completed Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01884428Phase 1 · unknown Study of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma · 119 trials list this drug (2 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01090973Phase 2 · terminated Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) · 119 trials list this drug (2 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01115036Phase 2 · withdrawn A Panobinostat Presurgery · 119 trials list this drug (2 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01528501Phase 2 · terminated Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008) · 119 trials list this drug (2 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01136499Phase 2 · completed Efficacy and Safety Assessment of Oral LBH589 in Adult Patients With Advanced Soft TIssue Sarcoma After Pre-treatment Failure · 119 trials list this drug (2 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00962507Phase 1 · completed Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma · 119 trials list this drug (2 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00412997Phase 1 · completed LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma · 119 trials list this drug (2 active) | — | — | Neoplasm,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00699296Phase 2 · terminated Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma · 119 trials list this drug (2 active) | — | — | Adult T-Cell Leukemia/Lymphoma,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00472368Phase 1 · completed A Study to Determine the Absorption, Distribution, Metabolism, and Excretion of LBH589 · 119 trials list this drug (2 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00873002Phase 1 · terminated Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by Surgery · 119 trials list this drug (2 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00690677Phase 2 · completed Phase II Trial of LBH589 in Refractory Colorectal Cancer · 119 trials list this drug (2 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00848523Phase 2 · terminated Study of LBH589 (Panobinostat) to Treat Malignant Brain Tumors · 119 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00419536Phase 1 · terminated Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone · 119 trials list this drug (2 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |